cannabis indica

AVC

termo de indexação original: Stroke

O acervo do Cannabis Indica reúne 153 estudos científicos que tocam a condição AVC, publicados entre 1981 e 2024. Pela leitura automatizada, 112 (73%) foram classificados como favoráveis, 10 (7%) como inconclusivos e 31 (20%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (70 estudos), seguido de estudo em animais (62). Os compostos mais presentes são Canabinoide Sintético (não especificado), Anandamida (AEA) e Endocanabinoide (não especificado). Aparece com frequência ao lado de Doenças Cardiovasculares (DCV), Inflamação e Doenças Neurodegenerativas.

Estudos indexados
153
Período coberto
1981–2024
Favoráveis
112 · 73%
Inconclusivos
10 · 7%
Desfavoráveis
31 · 20%
Termo original
Stroke

O acervo em números

Tipo de estudo

Metanálise70
Estudo em Animais62
Estudo Laboratorial9
Ensaio Clínico Duplo-Cego6
Ensaio Clínico4
Metanálise Clínica2

Direção do resultado

Favorável112
Inconclusivo10
Desfavorável31

Por década

1980s1
1990s2
2000s6
2010s69
2020s75

153 estudos

Filtrar e buscar no acervo →
  1. 2024

    Association of Cannabis Use With Cardiovascular Outcomes Among US Adults

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)Infarto
  2. 2024

    Vasoactive and Antifibrotic Properties of Cannabinoids and Applications to Vasospastic/Vaso-Occlusive Disorders: A Systematic Review

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)Lesão de Reperfusão
  3. 2023

    Cannabis-Induced ST-Segment Elevation Myocardial Infarction With Possible Coronary Artery Dissection: A Case Report

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+7
  4. 2023

    Exploring the Neuroprotective Effects of Spirulina platensis: Insights Into Hemorrhagic Volume and Histological Outcomes

  5. 2023

    Geriatric Pharmacotherapy Case Series: Potential Drug Interactions With Antiplatelet Medications and Cannabidiol-A Focus on P2Y12 Inhibitors

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)+2
  6. 2023

    Instant Detection of Synthetic Cannabinoids on Physical Matrices, Implemented on a Low-Cost, Ultraportable Device

  7. 2023

    Reversible cerebral vasoconstriction syndrome associated with probable drug poisoning

  8. 2023

    The use of cannabidiol as a novel treatment for oral stereotypic behaviour (crib-biting) in a horse

    FavorávelEstudo em AnimaisDorInflamaçãoAnsiedadeEndocanabinoide (não especificado)+12
  9. 2022

    A Case of Synthetic Cannabinoid (K2)-Induced Posterior Reversible Encephalopathy Syndrome (PRES)

  10. 2022

    Adverse Effects of Cannabinoids and Tobacco Consumption on the Cardiovascular System: A Systematic Review

  11. 2022

    Antioxidant and anti-apoptotic effects of cannabidiol in model of ischemic stroke in rats

    FavorávelEstudo em AnimaisEstresse Oxidativo
  12. 2022

    Borneol enhances the protective effect against cerebral ischemia/reperfusion injury by promoting the access of astragaloside IV and the components of Panax notoginseng saponins into the brain

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Lesão de Reperfusão
  13. 2022

    Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study

    InconclusivoEnsaio Clínico Duplo-CegoTetraidrocanabinol (THC)THC:CBD Farmacêutico
  14. 2022

    Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection

  15. 2022

    Cannabis Use and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage

    DesfavorávelMetanálise
  16. 2022

    Chronic health conditions, acute health events, and healthcare utilization among adults over age 50 in Hawai'i who use cannabis: A matched cohort study

    DesfavorávelMetanáliseDorEfeitos Adversos da CannabisDor — Crônica+7
  17. 2022

    Drugs of Misuse: Focus on Vascular Dysfunction

  18. 2022

    Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials

    FavorávelMetanálise ClínicaEsclerose MúltiplaDoença de ParkinsonLesões da Medula Espinhal+1
  19. 2022

    Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty

  20. 2022

    Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis

  21. 2022

    Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders

  22. 2022

    Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies

    DesfavorávelMetanáliseDorCâncerInflamaçãoAnandamida (AEA)THC Farmacêutico+14
  23. 2022

    LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnsiedadeAyahuasca+6
  24. 2022

    Marijuana and thromboembolic events in geriatric trauma patients: The cannabinoids clots correlation!

  25. 2022

    Nabiximols effect on blood pressure and heart rate in post-stroke patients of a randomized controlled study

  26. 2022

    Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders

  27. 2022

    Neuroprotective effects of synthetic borneol and natural borneol based on the neurovascular unit against cerebral ischaemic injury

    FavorávelEstudo Laboratorial
  28. 2022

    Omega 3 Fatty Acid and Cannabidiol Prolong Lifespan and Ameliorates Brain Ischaemia in Mice Fed Chronic High Fat Diet

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoObesidadeÔmega-3+1
  29. 2022

    Tetrahydrocannabinol-Positive Trauma Patients With Traumatic Brain Injury

    FavorávelMetanáliseTraumatismo Cranioencefálico
  30. 2022

    The Association of Cannabis Use Disorder with Acute Limb Ischemia and Critical Limb Ischemia

    DesfavorávelMetanáliseDependência QuímicaInflamaçãoEfeitos Adversos da Cannabis+5
  31. 2022

    The Effect of Oleoylethanolamide (OEA) Add-On Treatment on Inflammatory, Oxidative Stress, Lipid, and Biochemical Parameters in the Acute Ischemic Stroke Patients: Randomized Double-Blind Placebo-Controlled Study

    FavorávelEnsaio Clínico Duplo-CegoDorInflamaçãoAnsiedadeAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+7
  32. 2022

    Use of Marijuana: Effect on Brain Health: A Scientific Statement From the American Heart Association

    DesfavorávelMetanáliseDisfunção Cognitiva
  33. 2022

    β-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats

    FavorávelEstudo em Animais
  34. 2022

    Δ9-Tetrahydrocannabinol (Δ9-THC) Improves Ischemia/Reperfusion Heart Dysfunction and Might Serve as a Cardioprotective Agent in the Future Treatment

  35. 2021

    1,8-cineole ameliorates ischaemic brain damage via TRPC6/CREB pathways in rats

    FavorávelEstudo em Animais
  36. 2021

    A Review of the Potential Use of Pinene and Linalool as Terpene-Based Medicines for Brain Health: Discovering Novel Therapeutics in the Flavours and Fragrances of Cannabis

    FavorávelMetanáliseInflamaçãoAnsiedadeDepressão+5
  37. 2021

    Adverse events of recreational cannabis use reported to the French addictovigilance network (2012-2017)

    DesfavorávelMetanáliseCâncerEfeitos Adversos da CannabisDependência — Cannabis+4
  38. 2021

    Borneol-modified tanshinone IIA liposome improves cerebral ischemia reperfusion injury by suppressing NF-κB and ICAM-1 expression

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Lesão de Reperfusão
  39. 2021

    Cannabidiol and Other Cannabinoids in Demyelinating Diseases

    FavorávelMetanáliseEsclerose MúltiplaTraumatismo Cranioencefálico
  40. 2021

    Cannabidiol Confers Neuroprotection in Rats in a Model of Transient Global Cerebral Ischemia: Impact of Hippocampal Synaptic Neuroplasticity

    FavorávelEstudo em AnimaisDisfunção Cognitiva
  41. 2021

    Cannabis use disorder and perioperative outcomes in vascular surgery

  42. 2021

    Differential contribution of CB1, CB2, 5-HT1A, and PPAR-γ receptors to cannabidiol effects on ischemia-induced emotional and cognitive impairments

    FavorávelEstudo em AnimaisAnsiedadeDisfunção Cognitiva
  43. 2021

    Differentially expressed genes induced by β-caryophyllene in a rat model of cerebral ischemia-reperfusion injury

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Lesão de Reperfusão
  44. 2021

    Effect of Cannabinoid 2 Receptor Modulation on the Peripheral Immune Response in Central Nervous System Injury-Induced Immunodeficiency Syndrome

  45. 2021

    Effects of Cannabidiol and Beta-Caryophyllene Alone or in Combination in a Mouse Model of Permanent Ischemia

    FavorávelEstudo em Animais
  46. 2021

    Eucalyptol ameliorates early brain injury after subarachnoid haemorrhage via antioxidant and anti-inflammatory effects in a rat model

    FavorávelEstudo em AnimaisInflamaçãoEstresse Oxidativo
  47. 2021

    Juvenile cannabidiol chronic treatments produce robust changes in metabolic markers in adult male Wistar rats

    InconclusivoEstudo em AnimaisDoenças Cardiovasculares (DCV)DiabetesSíndrome Metabólica
  48. 2021

    Lethal case of myocardial ischemia following overdose of the synthetic cannabinoid ADB-FUBINACA

  49. 2021

    Marijuana-related Reversible Cerebral Vasoconstriction Syndrome

    DesfavorávelMetanálise
  50. 2021

    Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids

  51. 2021

    Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications

    FavorávelMetanálise
  52. 2021

    Neuroprotective Potential of Limonene and Limonene Containing Natural Products

    FavorávelMetanáliseAnsiedadeEpilepsiaDoenças Neurodegenerativas+2
  53. 2021

    Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Lesão de Reperfusão
  54. 2021

    Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation

  55. 2021

    Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

  56. 2021

    Progress in Borneol Intervention for Ischemic Stroke: A Systematic Review

    FavorávelMetanálise
  57. 2021

    Protective Effects of Cannabidivarin and Cannabigerol on Cells of the Blood–Brain Barrier Under Ischemic Conditions

  58. 2021

    Psychedelics for Brain Injury: A Mini-Review

    FavorávelMetanáliseEstresse OxidativoTraumatismo Cranioencefálico
  59. 2021

    Recreational cannabis use causing non-ischaemic cardiomyopathy and cardioembolism in a young adult

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)
  60. 2021

    Role of PI3K/Akt axis in mitigating hippocampal ischemia-reperfusion injury via CB1 receptor stimulation by paracetamol and FAAH inhibitor in rat

    FavorávelEstudo em AnimaisCOVID-19Anandamida (AEA)Endocanabinoide (não especificado)+1
  61. 2021

    Stroke and cannabis use in patients with no cardiovascular risk factors: a systematic review of case reports

    DesfavorávelMetanálise
  62. 2021

    Synergic Neuroprotection Between Ligusticum Chuanxiong Hort and Borneol Against Ischemic Stroke by Neurogenesis via Modulating Reactive Astrogliosis and Maintaining the Blood–Brain Barrier

    FavorávelEstudo em Animais
  63. 2021

    Tetrahydrocannabinol and cannabidiol as an oromucosal spray in a 1:1 ratio: a therapeutic option for patients with central post-stroke pain syndrome?

  64. 2021

    The Role of Cannabidiol in Neurological Disorders

  65. 2021

    Y-2 reduces oxidative stress and inflammation and improves neurological function of collagenase-induced intracerebral hemorrhage rats

    FavorávelEstudo em AnimaisInflamaçãoEstresse Oxidativo
  66. 2021

    β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19

    InconclusivoMetanáliseInflamaçãoDoenças Cardiovasculares (DCV)Disfunção Cognitiva+7
  67. 2020

    Cannabidiol alleviates hemorrhagic shock-induced neural apoptosis in rats by inducing autophagy through activation of the PI3K/AKT pathway

  68. 2020

    Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury

  69. 2020

    Cannabis-induced basal-mid-left ventricular stress cardiomyopathy: A case report

  70. 2020

    Endocannabinoids and Stroke Prevention: Review of Clinical Studies

    FavorávelMetanálise ClínicaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  71. 2020

    Impact of marijuana on venous thromboembolic events: Cannabinoids cause clots in trauma patients

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)InfartoCicatrização+1
  72. 2020

    Marijuana use and acute myocardial infarction: A systematic review of published cases in the literature

  73. 2020

    Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Mass Balance of Single and Continuous Intravenous Infusion of SPT-07A in Healthy Volunteers

    FavorávelEnsaio Clínico Duplo-Cego
  74. 2020

    Pharmacological treatment of central neuropathic pain: consensus of the Brazilian Academy of Neurology

  75. 2020

    Preparation, Characterization and in vivo Study of Borneol-Baicalin-Liposomes for Treatment of Cerebral Ischemia-Reperfusion Injury

    FavorávelEstudo em Animais
  76. 2019

    Attenuating Effect of α-Pinene on Neurobehavioural Deficit, Oxidative Damage and Inflammatory Response Following Focal Ischaemic Stroke in Rat

    FavorávelEstudo em Animais
  77. 2019

    Borneol for Regulating the Permeability of the Blood-Brain Barrier in Experimental Ischemic Stroke: Preclinical Evidence and Possible Mechanism

    FavorávelMetanáliseInflamaçãoEstresse Oxidativo
  78. 2019

    In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke neuroinflammation in rats: a positron emission tomography study

    FavorávelEstudo em Animais
  79. 2019

    Metabolomics Study on the Effects of Salvianolic Acid B and Borneol for Treating Cerebral Ischemia in Rats by Ultra-Performance Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry

    FavorávelEstudo em AnimaisInflamação
  80. 2019

    Rising Trends in Hospitalizations for Cardiovascular Events among Young Cannabis Users (18–39 Years) without Other Substance Abuse

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDoenças Cardiovasculares (DCV)Infarto+1
  81. 2019

    Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia

    FavorávelEstudo em Animais
  82. 2019

    The endocannabinoid system and stroke: A focused review

    FavorávelMetanáliseCanabinoide Sintético (não especificado)
  83. 2019

    The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review

    FavorávelMetanáliseDorDepressãoDoença de ParkinsonPalmitoiletanolamida (PEA)+4
  84. 2019

    Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention

  85. 2018

    Additive Neuroprotective Effect of Borneol With Mesenchymal Stem Cells on Ischemic Stroke in Mice

    FavorávelEstudo em Animais
  86. 2018

    An interaction between warfarin and cannabidiol, a case report

    FavorávelMetanáliseEpilepsiaDistúrbios de CoagulaçãoCBD Farmacêutico
  87. 2018

    Association of vascular indices with novel circulating biomarkers as prognostic factors for cardiovascular complications in patients with type 2 diabetes mellitus

  88. 2018

    Borneol and Α-asarone as adjuvant agents for improving blood-brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors

    FavorávelEstudo Laboratorial
  89. 2018

    Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor

    FavorávelEstudo em AnimaisDorEpilepsiaDor — Nociceptiva
  90. 2018

    Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia.

    FavorávelEstudo em Animais
  91. 2018

    Cannabinoid signalling in embryonic and adult neurogenesis: possible implications for psychiatric and neurological disorders.

  92. 2018

    Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats

  93. 2018

    Ischaemic cardiomyopathy and embolic stroke in a young adult with suspected synthetic cannabinoid use.

  94. 2018

    Long-term depression induced by endogenous cannabinoids produces neuroprotection via astroglial CB1R after stroke in rodents.

  95. 2018

    Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database.

    DesfavorávelMetanálise
  96. 2018

    Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model

    FavorávelEstudo em AnimaisCâncerInflamaçãoEstresse Oxidativo+8
  97. 2018

    Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia

    FavorávelEstudo em AnimaisPalmitoiletanolamida (PEA)Virodamina (O-AEA)
  98. 2018

    Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery Occlusion and Reperfusion

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Lesão de ReperfusãoResveratrol
  99. 2018

    The protective roles of L-borneolum, D-borneolum and synthetic borneol in cerebral ischaemia via modulation of the neurovascular unit

    FavorávelEstudo em AnimaisInflamação
  100. 2017

    (+)-Borneol is neuroprotective against permanent cerebral ischemia in rats by suppressing production of proinflammatory cytokines

    FavorávelEstudo em Animais
  101. 2017

    A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia

    FavorávelMetanáliseInflamaçãoDisfunção CognitivaPsicose+5
  102. 2017

    Anti-excitotoxic effects of cannabidiol are partly mediated by enhancement of NCX2 and NCX3 expression in animal model of cerebral ischemia.

    FavorávelEstudo em Animais
  103. 2017

    Borneol Attenuates Ultrasound-Targeted Microbubble Destruction-Induced Blood–Brain Barrier Opening in Focal Cerebral Ischemia

    FavorávelEstudo em Animais
  104. 2017

    Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neuron.

  105. 2017

    Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke.

    FavorávelEstudo em AnimaisDoenças Neurodegenerativas
  106. 2017

    Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke.

    FavorávelEstudo em AnimaisCanabinoides Sintéticos SR-xCanabinoides Sintéticos JWH-x
  107. 2017

    Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention

  108. 2017

    Correlation Between Cannabidiol-Induced Reduction of Infarct Volume and Inflammatory Factors Expression in Ischemic Stroke Model

    FavorávelEstudo em Animais
  109. 2017

    Intra-cerebral cannabidiol infusion-induced neuroprotection is partly associated with the TNF-α/TNFR1/NF-кB pathway in transient focal cerebral ischaemia.

    FavorávelEstudo em Animais
  110. 2017

    Neuroprotective Effect of β-Caryophyllene on Cerebral Ischemia-Reperfusion Injury via Regulation of Necroptotic Neuronal Death and Inflammation: In Vivo and in Vitro

  111. 2017

    RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke

  112. 2017

    Role of cannabis in cardiovascular disorders.

  113. 2017

    Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia.

  114. 2017

    Strokes are possible complications of cannabinoids use

    InconclusivoMetanáliseIntoxicação por Cannabis Sintética
  115. 2017

    The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations

    FavorávelMetanáliseDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+7
  116. 2016

    A CB2-Selective Cannabinoid Suppresses T-cell Activities and Increases Tregs and IL-10

  117. 2016

    Cannabidiol, neuroprotection and neuropsychiatric disorders.

    FavorávelMetanáliseInflamaçãoAnsiedadeDoenças Cardiovasculares (DCV)+8
  118. 2016

    Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways

    InconclusivoEstudo em AnimaisDoenças Neurodegenerativas2-Araquidonoilglicerol (2-AG)Ômega-3
  119. 2016

    Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study.

    InconclusivoMetanálise
  120. 2016

    Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage.

    FavorávelMetanálise
  121. 2016

    Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States.

    DesfavorávelMetanálise
  122. 2016

    Role of hypothalamic cannabinoid receptors in post-stroke depression in rats

    FavorávelEstudo em AnimaisDepressão
  123. 2016

    The CB1 Antagonist, SR141716A, Is Protective in Permanent Photothrombotic Cerebral Ischemia

    FavorávelEstudo em AnimaisCanabinoides Sintéticos SR-x
  124. 2016

    The Protective Cardiac Effects of β-Myrcene After Global Cerebral ıschemia/Reperfusion in C57BL/J6 Mouse

  125. 2015

    A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice

    FavorávelEstudo em AnimaisDisfunção CognitivaCanabinoides Sintéticos O-x
  126. 2015

    Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice

  127. 2015

    Cannabinoids in experimental stroke: a systematic review and meta-analysis

    FavorávelEstudo em AnimaisAnandamida (AEA)Tetraidrocanabinol (THC)+7
  128. 2015

    Cannabinoids In Neurodegenerative Disorders And Stroke/Brain Trauma: From Preclinical Models To Clinical Applications

  129. 2015

    Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity

    FavorávelEstudo em Animais2-Araquidonoilglicerol (2-AG)
  130. 2015

    Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals

  131. 2015

    Time-Dependent Protection of CB2 Receptor Agonist in Stroke

    FavorávelEstudo em AnimaisCanabinoides Sintéticos AM-x
  132. 2014

    A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid

  133. 2014

    Comparative pharmacokinetics of borneol in cerebral ischemia-reperfusion and sham-operated rats

    FavorávelEstudo em Animais
  134. 2014

    Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome.

    FavorávelMetanáliseImunodeficiência por Trauma
  135. 2014

    Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice.

    FavorávelEstudo em Animais
  136. 2013

    Activation of cannabinoid CB2 receptor-mediated AMPK/CREB pathway reduces cerebral ischemic injury.

    FavorávelEstudo em AnimaisCanabinoides Sintéticos AM-x
  137. 2013

    Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury.

  138. 2013

    Ischemic stroke after use of the synthetic marijuana “spice”

  139. 2013

    Study on the anti-cerebral ischemia effect of borneol and its mechanism

    FavorávelEstudo em Animais
  140. 2012

    Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide

  141. 2011

    Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury

    FavorávelEstudo em AnimaisTraumatismo CranioencefálicoCanabinoides Sintéticos O-x
  142. 2011

    The multiplicity of action of cannabinoids: implications for treating neurodegeneration

  143. 2010

    Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: A neuroprotective therapeutic modality

  144. 2010

    Therapeutic Potential Of Non-Psychotropic Cannabidiol In Ischemic Stroke

    FavorávelMetanáliseDisfunção CognitivaDoença de AlzheimerDoença de Parkinson+2
  145. 2009

    Cannabinoid CB2 receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model

  146. 2007

    Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor‐independent myeloperoxidase‐inhibiting mechanism.

  147. 2007

    Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.

    FavorávelEstudo em AnimaisEpilepsia — FIRESCanabinoides Sintéticos SR-x
  148. 2007

    High-cholesterol feeding aggravates cerebral infarction via decreasing the CB1 receptor

    FavorávelEstudo em AnimaisObesidadeDiabetesSíndrome Metabólica+1
  149. 2003

    Drug-induced Hypothermia Reduces Ischemic Damage: Effects of the Cannabinoid HU-210

  150. 2000

    The importance of the endogenous cannabinoid system in various neuropsychiatric disorders

  151. 1999

    Cannabinoids as antioxidants and neuroprotectants.

  152. 1998

    Cannabidiol and Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

  153. 1981

    Treatment of human spasticity with delta 9-tetrahydrocannabinol.

    FavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaLesões da Medula Espinhal

Continue por aqui

Perguntas frequentes

Quantos estudos sobre avc estão indexados no acervo?
São 153 estudos, publicados entre 1981 e 2024. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 70 · Estudo em Animais: 62 · Estudo Laboratorial: 9 · Ensaio Clínico Duplo-Cego: 6 · Ensaio Clínico: 4 · Metanálise Clínica: 2. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 112 favoráveis, 10 inconclusivos e 31 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. AVC — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/avc/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). AVC — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/avc/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.